Assignee
ABBVIE DEUTSCHLAND
DE·77 granted patents·82 pending applications·117 citations·filing 2012–2024
Top patents by PatentIndex Score
159 records- 0194US12098192B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2024·Granted Sep 24, 2024·2 cites·20 claims
- 0292US10822403B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2018·Granted Nov 3, 2020·5 cites·14 claims
- 0391US12098189B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2020·Granted Sep 24, 2024·2 cites·24 claims
- 0487US10118958B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2012·Granted Nov 6, 2018·9 cites·38 claims
- 0587US10118926B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 6, 2018·10 cites·6 claims
- 0687US9828381B2Substituted pyrazolopyrimidines and method of useABBVIE DEUTSCHLAND·Filed 2016·Granted Nov 28, 2017·3 cites·14 claims
- 0787US9205027B2Process for producing a solid dispersion of an active ingredientABBVIE DEUTSCHLAND·Filed 2013·Granted Dec 8, 2015·9 cites·27 claims
- 0887US8865650B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 21, 2014·9 cites·32 claims
- 0986US9394360B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 19, 2016·6 cites·2 claims
- 1086US9102722B2Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2013·Granted Aug 11, 2015·6 cites·5 claims
- 1186US2025179159A1Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 1284US10106602B2Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Oct 23, 2018·3 cites·11 claims
- 1384US9592231B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 14, 2017·6 cites·16 claims
- 1484US8623819B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2013·Granted Jan 7, 2014·6 cites·15 claims
- 1583US9605069B2Antibodies against the RGM a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Mar 28, 2017·3 cites·11 claims
- 1683US9527856B2Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2015·Granted Dec 27, 2016·4 cites·38 claims
- 1781US9636398B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2012·Granted May 2, 2017·5 cites·16 claims
- 1879US10464976B2Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 5, 2019·2 cites·31 claims
- 1979US9656955B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 23, 2017·2 cites·20 claims
- 2079US2024197757A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2023·Application pending·0 cites
- 2177US10047121B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Aug 14, 2018·2 cites·18 claims
- 2275US9790203B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 17, 2017·2 cites·26 claims
- 2375US9200005B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 2475US9169253B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 27, 2015·1 cites·23 claims
- 2575US8895749B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 25, 2014·2 cites·11 claims
- 2674US9365643B2Antibodies that bind to repulsive guidance molecule A (RGMA)ABBVIE DEUTSCHLAND·Filed 2014·Granted Jun 14, 2016·1 cites·13 claims
- 2773US10836688B2Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcelluloseABBVIE DEUTSCHLAND·Filed 2020·Granted Nov 17, 2020·1 cites·20 claims
- 2873US9856220B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 2973US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 3073US9422264B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 23, 2016·1 cites·21 claims
- 3172US9096619B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Aug 4, 2015·1 cites·20 claims
- 3272US2022110951A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 3371US8957089B2Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 17, 2015·1 cites·15 claims
- 3471US2021238270A1Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 3571US2025296917A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 3671US2021230260A1Antibodies against the rgm a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 3771US2022018855A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 3870US9487505B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 8, 2016·1 cites·8 claims
- 3970US2021277097A1Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degenerationABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 4070US2021093649A1Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitorABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 4169US9475808B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2015·Granted Oct 25, 2016·1 cites·33 claims
- 4269US9394363B2Antibodies to receptor of advanced glycation end products (RAGE) and uses thereofABBVIE DEUTSCHLAND·Filed 2012·Granted Jul 19, 2016·1 cites·10 claims
- 4369US9163019B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Oct 20, 2015·1 cites·26 claims
- 4469US2024075114A1IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2022·Application pending·0 cites
- 4568US11427598B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE DEUTSCHLAND·Filed 2020·Granted Aug 30, 2022·0 cites·10 claims
- 4668US9388148B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·1 cites·6 claims
- 4767US9402909B2Pharmaceutical dosage form comprising polymeric carrier compositionABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 2, 2016·1 cites·10 claims
- 4866US8846741B2N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2012·Granted Sep 30, 2014·1 cites·19 claims
- 4966US2015037348A1Human antibodies that bind human il-12 and methods for producingABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 5064US2021353555A1Nanoparticles based on optionally alkoxylated poly(alkyl cyanoacrylates) having a defined degree of polymerizationABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
Showing the top 50 of 159 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ABBVIE DEUTSCHLAND files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →